Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    22381714 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Study to Evaluate the Safety, Pharmacokinetics and Tolerability of BMS-708163
Condition: Alzheimer's Disease
Interventions: Drug: BMS-708163 (Gamma-Secretase Inhibitor);   Drug: Placebo matching BMS-708163

Indicates status has not been verified in more than two years